From an article by Ludmila Morozova-Buss on TechNative:
Women have played a role in computer technology since its inception.
Many credit Ava Lovelace as the first computer programmer, in a time before computers even existed, and women from Grace Hopper to the women who worked with Alan Turing at Bletchley Park were key in the development and adoption of modern computing devices. However, the number of women working in tech dropped significantly after the 1980s, and the percentage of tech employees who are female lags far behind other fields, including business, law, and medicine. Still, there are signs of progress, and understanding the statistics pertaining to women in tech is essential for understanding the problems and addressing them.
PwC recently looked at the role of women in tech in the UK. In STEM fields, women accounted for only 15 percent of employees. More distressingly, there are few signs that this number will rise without extra action, as only 15.8 percent of undergraduates in STEM fields are women. Leadership examples can be key toward encouraging more participation among women, yet only five percent of leadership positions in STEM fields are held by women. In PwC’s report “The Female Millennial — The New Era of Talent,” researchers found that young women want to work with employers with a strong history of inclusion, diversity, and equality. Many women see the low number of women in tech and choose to enter other fields.
The PwC reports highlights the problems these disparities create for UK companies. Two-thirds of CEOs in the UK claim to have difficulty hiring people with digital skills, a numbers that significantly exceeds the 43 percent of CEOs who claimed the same in the US and the 24 percent of CEOs in China. Countless studies have shown a shortage of tech workers in the UK and around the world, and this number will only rise. Increasing the number of women entering tech is perhaps the most powerful tool for alleviating this burden.
Ludmila Morozova-Buss is Vice President of Public Relations and Media Communications at Global Institute for IT Management (GIIM) & Executive Partner at Brooks Consulting International (BCI) – a boutique global marketing, branding, and government relations firm specializing in Cybersecurity and Emerging Technologies.
Largest-Ever Physics Survey Raises New Doubts About Our Model of the Universe
Physicists around the world remain deeply divided on key mysteries of the universe, from dark matter to quantum gravity. The standard cosmological model failed to gain majority support, and no leading theory dominated the [...]
Scientists Just Overturned a 100-Year-Old Belief About Bacteria in the Lungs
New findings raise questions about the role of microbes living in the lungs. More than 35 trillion bacteria live throughout the human body, forming microbiomes in the gut, mouth, lungs, skin, and urogenital tract. [...]
GHCE Concept
From the preface of the book Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artificial Intelligence, Edited by Frank Boehm: Since the publication of my first book (Nanomedical Device and Systems [...]
Novartis, Ionis drug failure spurs questions
Pelacarsen didn’t protect heart health despite lowering levels of a protein particle, “Lp(a),” in a large clinical trial — a result with important implications for cardiovascular drug research. Dive Brief: An RNA drug from [...]
New injectable treatment helps the brain rebuild after stroke
Biomedical engineers at Duke University have created an injectable biomaterial that may help the brain recover from damage left behind by an ischemic stroke. In experiments with mice, the material transformed the cavity created [...]
Scientists Discover a Hidden “Immune Organ” Inside the Skull
Researchers discovered lymph node-like immune hubs inside skull bone marrow that appear to act as rapid-response centers for the brain. For decades, the brain was thought to operate largely apart from the immune system. [...]
Engineered tRNAs and lipid nanoparticles target nonsense mutation cystic fibrosis
Researchers have developed a potential new approach for treating a form of cystic fibrosis caused by so-called nonsense mutations, combining chemically modified transfer RNAs with lipid nanoparticles designed to deliver the therapy directly to [...]
New pancreatic cancer drug carries a $39,800 monthly list price
A groundbreaking treatment for one of the most common forms of pancreatic cancer has been approved in pill form by the FDA. Revolution Medicines’ oral tablet daraxonrasib, branded as Rasonque, reduced the risk of [...]
Leave A Comment